Bicalutamide Tablet, Film Coated
Product Images NDC 47335-485

4 FDA label images from Sun Pharmaceutical Industries, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bicalutamide (NDC 47335-485). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bicalutamide-figure-1 (Bicalutamide Figure 1)

Bicalutamide-figure-1 (Bicalutamide Figure 1)
A Kaplan-Meier survival curve graph comparing the probability of death over time in days between two antiandrogen treatment groups: bicalutamide plus LHRH-A and flutamide plus LHRH-A. The y-axis represents the proportion surviving, and the x-axis shows days to death up to approximately 1825 days (5 years).*
FDA Label Image

Bicalutamide-figure-2 (Bicalutamide Figure 2)

Bicalutamide-figure-2 (Bicalutamide Figure 2)
A Kaplan-Meier curve showing time to progression for two antiandrogen treatment groups: bicalutamide plus LHRH-A and flutamide plus LHRH-A. The vertical axis represents the proportion not progressing, and the horizontal axis is days to progression, spanning from 0 to 1825 days. The graph compares progression over time between the two groups.*
FDA Label Image

Bicalutamide-structure (Bicalutamide Structure)

Bicalutamide-structure (Bicalutamide Structure)
Chemical structure of bicalutamide, showing its molecular composition with the formula C18H14N2O4F4S. The diagram includes rings, functional groups, and atomic connections characteristic of the molecule.*
FDA Label Image

Spl Bicalutamide Tablets

Spl Bicalutamide Tablets
Label for bicalutamide tablets, USP 50 mg, a film-coated oral tablet. The label indicates a quantity of 30 tablets and directs the pharmacist to dispense with a patient information leaflet. It includes the NDC 47335-485-83 and is labeled by Sun Pharmaceutical Industries, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.